237 related articles for article (PubMed ID: 9833750)
1. Gender and survival after AIDS in Rio de Janeiro, Brazil.
Santoro-Lopes G; Harrison LH; Moulton LH; Lima LA; de Pinho AM; Hofer C; Schechter M
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):403-7. PubMed ID: 9833750
[TBL] [Abstract][Full Text] [Related]
2. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
3. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
[TBL] [Abstract][Full Text] [Related]
5. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
Fonseca LA; Reingold AL; Casseb JR; Brigido LF; Duarte AJ
Int J Epidemiol; 1999 Dec; 28(6):1156-60. PubMed ID: 10661662
[TBL] [Abstract][Full Text] [Related]
6. Differential trends in mortality from AIDS in men and women in Brazil (1984-1995).
Lowndes CM; Bastos FI; Giffin KM; Vaz dos Reis AC; d'Orsi E; Alary M
AIDS; 2000 Jun; 14(9):1269-73. PubMed ID: 10894292
[TBL] [Abstract][Full Text] [Related]
7. Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
Grinsztejn B; Veloso VG; Friedman RK; Moreira RI; Luz PM; Campos DP; Pilotto JH; Cardoso SW; Keruly JC; Moore RD
AIDS; 2009 Oct; 23(16):2107-14. PubMed ID: 19770698
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
9. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
11. Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003.
Campos DP; Ribeiro SR; Grinsztejn B; Veloso VG; Valente JG; Bastos FI; Morgado MG; Gadelha AJ
AIDS; 2005 Oct; 19 Suppl 4():S22-6. PubMed ID: 16249649
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
13. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.
Hogg RS; Heath KV; Yip B; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
JAMA; 1998 Feb; 279(6):450-4. PubMed ID: 9466638
[TBL] [Abstract][Full Text] [Related]
14. Survival and medical intervention in southern Brazilian AIDS patients.
Santos B; Beck EJ; Peixoto MF
Int J STD AIDS; 1994; 5(4):279-83. PubMed ID: 7948159
[TBL] [Abstract][Full Text] [Related]
15. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
16. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
[TBL] [Abstract][Full Text] [Related]
17. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
18. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
[TBL] [Abstract][Full Text] [Related]
19. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992.
Colford JM; Segal M; Tabnak F; Chen M; Sun R; Tager I
Am J Epidemiol; 1997 Jul; 146(2):115-27. PubMed ID: 9230773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
